Microport
Microport
Microport mainly engages in medical research and medical equipment production.
MicroPort, established in 1998, is a medical device manufacturer. The company's products cover ten major fields, such as implants, orthopedic medical devices, aortic and puncture vascular intervention products, electrophysiological medical devices and nerve implant products. Founded by Chang Yaohua, it went public on the Hong Kong Stock Exchange. The shareholders are Otsuka, Maxwell Maxcare Science, Shanghai ZJ Hi-Tech Investment, Starwick Investments. Microport's direct competitors include Lepu Medical and Weigao.
- All
- News
- Analysis
- Research
Briefing May 24, 2022 09:50 AM
· Healthcare
Shuoxing biological innovative nano multi antibody sm3321 was approved by ind in the United States
Briefing May 24, 2022 09:45 AM
· Healthcare
Temasek's reduction of Cinda biological
In-depth
Healthcare
EqualOcean Sector Quarterly Report - Healthcare Sectors
To help worldwide investors keep track of what is happening in each industry or sector and the related hot spots, we launched the EqualOcean Sector Quarterly Report series, which gathers notable information and statistics in each quarter.
Apr 07, 2022 01:44 PM
Briefing Apr 27, 2022 06:47 PM
· Healthcare
Medtronic's world's first self expanding pulmonary valve was first-class recalled
Apr 22, 2021 03:11 PM
Research
Healthcare, Consumer Staples, TechnologyWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Aug 09, 2020 12:23 AM
Briefing Apr 26, 2022 03:52 PM
· Healthcare
Inactivated vaccine against novel coronavirus of Chinese medicine Zhongsheng Omicron mutant approved for clinical use
Briefing Apr 26, 2022 03:43 PM
· Healthcare
The new crown inactivated vaccine of Sinopharm Zhongsheng Omicron mutant was approved clinically.
Briefing Apr 26, 2022 11:20 AM
· Healthcare
Yanye said that its Xinguan oral drug s-217622 can quickly eliminate the virus
Briefing Apr 26, 2022 11:11 AM
· Healthcare
Bojian abandons Alzheimer's disease drug aduhelm and goes public in the EU
Briefing Apr 25, 2022 09:35 AM
· Healthcare
Upside foods, a cell meat enterprise, received US $400 million in financing, the highest single transaction in the industry
Briefing Apr 25, 2022 09:30 AM
· Healthcare
Lingfu biology, an experimental animal research service provider, completed a pre-A round of financing of more than 200 million yuan
Briefing Dec 28, 2021 11:59 PM
· Healthcare
Minimally invasive medicine proposes to spin off minimally invasive brain science and list it independently on the main board of the stock exchange
Financials, Technology, Healthcare
Hang Seng Introduces Metaverse, Genomics, and Oncology Indexes
On May 23rd, Hang Seng Indexes Company Launches Hang Seng China Metaverse Index and the Hang Seng Shanghai-Shenzhen-Hong Kong Genomics and Oncology Index. These two indexes are created to capture the performance of companies that deal with Metaverse, Genomics, and Oncology concepts, which have become increasingly popular among investors.
May 23, 2022 04:54 PM
Healthcare, Financials
Ophthalmological Medtech Startup Raises Tens of Mns of CNY in Series C Funding
Founded in 2011, Suzhou Microclear Medical is engaged in the ophthalmology and optometry imaging field. Microclear integrates self-developed components with artificial intelligence technology to provide high-quality devices and services for hospitals and basic medical institutes across the world.
May 23, 2022 04:18 PM
Briefing Oct 30, 2021 10:44 AM
· Healthcare
Minimally invasive group investment holding Argus strengthens the multi-dimensional layout of precision medicine in the pan vascular field
Briefing Dec 11, 2020 09:57 PM
· Healthcare
Minimally invasive medical treatment: considering the separation of minimally invasive medical robot and independent listing
See more
Related Companies
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.